Convalescent Plasma Versus Hyperimmune Immunoglobulins

Clin Infect Dis. 2023 Nov 11;77(9):1356-1357. doi: 10.1093/cid/ciad406.

Authors

Daniele Focosi¹, Massimo Franchini², Emanuele Nicastri³, David J Sullivan⁴, Arturo Casadevall⁴

Affiliations

¹ North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.
² Division of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantua, Italy.
³ Division of Infectious Diseases, National Institute for Infectious Diseases "Lazzaro Spallanzani," Rome, Italy.
⁴ Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

PMID: 37399022
DOI: 10.1093/cid/ciad406

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19*
Humans
Immunoglobulins* / therapeutic use

Substances

Immunoglobulins